Biologic Drugs With Mechanism of Action: Interleukin 17 Receptor A Antagonists
✉ Email this page to a colleague
Biologic Drugs With Mechanism of Action: Interleukin 17 Receptor A Antagonists
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Valeant Pharmaceuticals Luxembourg S.à.r.l. | SILIQ | brodalumab | Injection | 761032 | 2017-02-15 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Patent Expiration |